TNFRSF1B and acute myeloid leukemia: YTHDF2 promoted tumorigenesis of acute myeloid leukemia (AML) through recognizing m6A on, and promoting degradation of, TNFR2 mRNA, resulting in reduced sensitivity of AML Cells to TNF21.